Stages:
Locations:
Min Investment:
Max Investment:
Target Investment:
2007
2022
2007 - 2022
Representing Abingworth, have served on the Boards of Chiasma, Dicerna Pharmaceuticals, Dynex Technologies, Hydra Biosciences, IFM Therapeutics, IFM Due, IFM Tre, IFM Quattro, Magellan Diagnostics, Personalis and PrimeraDx, and as a Board observer at Atsena Therapeutics and Nido Biosciences. Abingworth is a life-sciences venture capital firm that invests mainly in companies discovering and developing novel therapeutics for unmet clinical needs.
2003 - 2007
2003 - 2007
1997 - 2003
1997 - 2003
1996 - 1997
1996 - 1997
1992 - 1996
1992 - 1996
1986 - 1992
1989 - 1992
1986 - 1990
1978 - 1986
1978 - 1986
1975 - 1978
1975 - 1978